Top Markets
Coin of the day
Hunan Er-Kang Pharmaceutical Co., Ltd Hunan Er-Kang Pharmaceutical Co., Ltd

Hunan Er-Kang Pharmaceutical Co., Ltd

300267
Rangering i aksjer #9472
Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that... Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.
Aksjekurs
$0.48835979
Sist synkronisert: 2026-08-28
Markedsverdi
$1.01B
Endring (1 dag)
-1.46%
Endring (1 år)
-9.78%
Land
CN
Handel Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

Kategori

Aksjeprishistorikk for Hunan Er-Kang Pharmaceutical Co., Ltd (300267)
Høyeste sluttskurs: $0.48 den 2026-08-01

Laveste sluttskurs: $0.33 den 2011-09-01
Aksjeprishistorikk for Hunan Er-Kang Pharmaceutical Co., Ltd fra 2011 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 4.61%
2025 15.06%
2024 -5.32%
2023 -10.71%
2022 -23.27%
2021 -1.13%
2020 -14.38%
2019 35.50%
2018 -40.41%
2017 -48.71%
2016 -23.03%
2015 60.00%
2014 107.49%
2013 108.36%
2012 15.60%
2011 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$171.67 -
DE
$166.36 31.46%
DE
$37.84 25.87%
JP
$222.33 27.49%
CH
$21.19 17.16%
IN